In 2023, ischaemic heart disease mortality for Canadian men stood at an undisclosed baseline, with forecasted data suggesting a decline in the standardised rate per hundred thousand men. From 2024 to 2028, the projected year-on-year decreases are notable: 6.31% for 2025, 6.61% for 2026, 6.93% for 2027, and 7.29% for 2028. From 2024 to 2028, the compound annual growth rate (CAGR) indicates an average decline of 6.78% per year.
Looking ahead, it will be critical to monitor advancements in medical technology, healthcare accessibility, and preventive health strategies, which might further accelerate or stabilize the downward trend in mortality rates associated with ischaemic heart diseases among Canadian men.
